Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVera Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.90 | -$0.79 | -$0.86 |
| Q2 2025 | 1 | -$0.86 | -$0.86 | -$0.86 |
| Q3 2025 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2025 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q1 2026 | 1 | -$4.01 | -$4.01 | -$4.01 |
Vera Therapeutics, Inc. Earnings Date And Information
Vera Therapeutics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.85 earnings per share for the quarter, missing analysts' consensus estimates of $-0.69 by $0.16. The company had revenue of 0 for the quarter and had revenue of 1.86 M for the year. Vera Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.25 diluted earnings per share) and currently has a price-to-earnings ratio of -14.2. Vera Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based on prior year's report dates.
Vera Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.69 | -$0.85 | -0.16 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.58 | -$0.62 | -0.04 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.56 | $0 | |||
| 03/26/2024 | Q4 2023 | -$0.58 | $0 | |||
| 11/09/2023 | Q3 2023 | -$0.50 | -$0.45 | 0.05 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.69 | -$0.46 | 0.23 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.59 | -$0.79 | -0.2 | $0 | |
| 03/28/2023 | Q4 2022 | -$1.17 | $0 | |||
| 11/09/2022 | Q3 2022 | -$0.72 | -$0.89 | -0.17 | $0 | |
| 08/10/2022 | Q2 2022 | -$0.72 | -$0.55 | 0.17 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.67 | -$0.71 | -0.04 | $0 | |
| 03/25/2022 | Q4 2021 | -$0.79 | $0 | |||
| 11/10/2021 | Q3 2021 | -$0.60 | -$0.36 | 0.24 | $0 | |
| 08/16/2021 | Q2 2021 | -$0.39 | -$0.33 | 0.06 | $0 | |
| 06/24/2021 | Q1 2021 | -$0.23 | $0 | |||
| 12/31/2020 | Q4 2020 | -$2.09 | $0 | |||
| 09/29/2020 | Q3 2020 | -$1.09 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.88 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.61 | $0 |
Vera Therapeutics, Inc. Earnings: FAQ's
When is Vera Therapeutics, Inc.'s earnings date?
Vera Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based off last year's report dates.
How can I listen to Vera Therapeutics, Inc.'s earnings conference
call?
The conference call for Vera Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Vera Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Vera Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Vera Therapeutics, Inc. generate each year?
Vera Therapeutics, Inc. (:VERA) has a recorded annual revenue of $1.86 M.
How much profit does Vera Therapeutics, Inc. generate each year?
Vera Therapeutics, Inc. (:VERA) has a recorded net income of $1.86 M. Vera Therapeutics, Inc. has generated $-2.25 earnings per share over the last four quarters.
What is Vera Therapeutics, Inc.'s price-to-earnings ratio?
Vera Therapeutics, Inc. (:VERA) has a price-to-earnings ratio of -14.2 and price/earnings-to-growth ratio is 0.78.